“…The Cu(I) catalyzed azide-alkyne [3+2] cycloaddition (CuAAC) or 'click chemistry', initiated by Sharpless et al, has emerged as a powerful strategy for the design of sophisticated biomaterials with high levels of precision and control [18,19]. As reaction products of CuAAC, 1,2,3-triazoles are attractive constructs of target molecules due to their wide range of biological properties, such as antimicrobial [20], antitubercular [21], antimalarial [22], antibiotic [23], anticancer [24,25], cytotoxic agents [26,27], and antioxidant [28,29].…”